Matches in Nanopublications for { ?s ?p "Fosamprenavir calcium tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. The protease inhibitor-experienced patient trial was not large enough to reach a definitive conclusion. Once-daily administration of fosampranavir. tabletsplus ritonavir is not recommended for adult. protease. inhibitor-expertienced patients or any pediatric patients. younger than 6 months." ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion wasQuotedFrom "Fosamprenavir calcium tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. The protease inhibitor-experienced patient trial was not large enough to reach a definitive conclusion. Once-daily administration of fosampranavir. tabletsplus ritonavir is not recommended for adult. protease. inhibitor-expertienced patients or any pediatric patients. younger than 6 months." provenance.
- assertion wasQuotedFrom "Fosamprenavir calcium tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. The protease inhibitor-experienced patient trial was not large enough to reach a definitive conclusion. Once-daily administration of fosampranavir. tabletsplus ritonavir is not recommended for adult. protease. inhibitor-expertienced patients or any pediatric patients. younger than 6 months." provenance.